KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.

The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.   


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://news.cornell.edu/stories/2021/02/antibiotic-tolerance-study-paves-way-new-treatments

https://www.miragenews.com/antibiotic-tolerance-study-paves-way-for-new-516267/



List of Articles
번호 제목 글쓴이 날짜 조회 수
142 허원도 교수님_머리에 빛을 비춰 신경세포 재생과 공간기억 향상 file 생명과학과 2020.04.27 4672
141 2020 Spring KAIST Compass 생명과학과 2020.05.07 3407
140 김광수 석좌교수님_한인과학자, 줄기세포 치료 첫 성공 생명과학과 2020.06.03 3732
139 전상용 교수님_ 면역항암제 효율 높인 나노입자 백신 개발 file 생명과학과 2020.06.17 3701
138 이승재 교수님_One More Key to Human Longevity Found After Worm Research 생명과학과 2020.07.03 11393
137 전상용교수님_항암제 표적 단백질을 약물 전달체로 쓴다?​ file 생명과학과 2020.08.26 3416
136 서경배재단 ‘올해의 신진 과학자’ 조원기 교수 선정 생명과학과 2020.09.16 4572
135 정현정교수_ 커피링 효과로 감염병 신속진단 기술 개발 생명과학과 2020.09.17 2791
134 정원석 교수_ 삼성전자, ‘세계 알츠하이머의 날’ 맞아 연구원 노력 담은 영상 공개 생명과학과 2020.09.21 3101
133 [한국의 AI 추격자들] 서범석·백승욱 루닛 창업자 file 생명과학과 2020.10.30 3580
132 조병관 교수님 _Newly discovered metabolic pathway uses single carbon gases as a feedstock file 생명과학과 2020.11.20 4277
131 정현정 교수님_도파민의 성질로 박테리아 생장의 실시간 탐지 기술 개발​ 생명과학과 2020.12.09 1890
130 김진우 교수님_생명의 신비상 장려상 수상 생명과학과 2020.12.24 2192
129 전상용 교수님_Researchers review future directions of nanomedicine development 생명과학과 2020.12.28 1504
128 정원석 교수님_Astrocytes eat connections to maintain plasticity in adult brains 생명과학과 2020.12.28 2414
127 정인경 교수님_KAIST, 전 세계 최대 규모의 3차원 암 게놈 지도 구축 생명과학과 2020.12.29 1802
126 김찬혁 교수님_인공지능 이용 면역항암 세포 3차원 분석기술 개발 생명과학과 2021.02.08 1732
125 오병하 교수님_자연에 없는 고감도 단백질 센서 제작 플랫폼 개발 생명과학과 2021.02.08 1277
124 김진우 교수님, 천주교 서울대교구 생명위원회 제 15회 '생명의 신비상' 수상 생명과학과 2021.02.18 1307
» 조병관 교수님_Antibiotic tolerance study paves way for new treatments 생명과학과 2021.02.19 2289
Board Pagination Prev 1 ... 11 12 13 14 15 16 17 18 19 20 ... 23 Next
/ 23